Global Viral Vaccines Market Research Report 2020

Global Viral Vaccines Market Research Report 2020

Table of Contents
1 Viral Vaccines Market Overview
1.1 Product Overview and Scope of Viral Vaccines
1.2 Viral Vaccines Segment by Type
1.2.1 Global Viral Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Viral Vaccines Segment by Application
1.3.1 Viral Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Research Institute
1.3.5 Others
1.4 Global Viral Vaccines Market Size Estimates and Forecasts
1.4.1 Global Viral Vaccines Revenue 2015-2026
1.4.2 Global Viral Vaccines Sales 2015-2026
1.4.3 Viral Vaccines Market Size by Region: 2020 Versus 2026
2 Global Viral Vaccines Market Competition by Manufacturers
2.1 Global Viral Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Viral Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global Viral Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Viral Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Viral Vaccines Market Competitive Situation and Trends
2.5.1 Viral Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Viral Vaccines Players (Opinion Leaders)
3 Viral Vaccines Retrospective Market Scenario by Region
3.1 Global Viral Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Viral Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Viral Vaccines Market Facts & Figures by Country
3.3.1 North America Viral Vaccines Sales by Country
3.3.2 North America Viral Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Viral Vaccines Market Facts & Figures by Country
3.4.1 Europe Viral Vaccines Sales by Country
3.4.2 Europe Viral Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Viral Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Viral Vaccines Sales by Region
3.5.2 Asia Pacific Viral Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Viral Vaccines Market Facts & Figures by Country
3.6.1 Latin America Viral Vaccines Sales by Country
3.6.2 Latin America Viral Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Viral Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Viral Vaccines Sales by Country
3.7.2 Middle East and Africa Viral Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Viral Vaccines Historic Market Analysis by Type
4.1 Global Viral Vaccines Sales Market Share by Type (2015-2020)
4.2 Global Viral Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global Viral Vaccines Price Market Share by Type (2015-2020)
4.4 Global Viral Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Viral Vaccines Historic Market Analysis by Application
5.1 Global Viral Vaccines Sales Market Share by Application (2015-2020)
5.2 Global Viral Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global Viral Vaccines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Viral Vaccines Business
6.1 GSK
6.1.1 Corporation Information
6.1.2 GSK Description, Business Overview and Total Revenue
6.1.3 GSK Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GSK Products Offered
6.1.5 GSK Recent Development
6.2 Merck
6.2.1 Merck Viral Vaccines Production Sites and Area Served
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Novartis
6.3.1 Novartis Viral Vaccines Production Sites and Area Served
6.3.2 Novartis Description, Business Overview and Total Revenue
6.3.3 Novartis Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Novartis Products Offered
6.3.5 Novartis Recent Development
6.4 Pfizer
6.4.1 Pfizer Viral Vaccines Production Sites and Area Served
6.4.2 Pfizer Description, Business Overview and Total Revenue
6.4.3 Pfizer Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer Products Offered
6.4.5 Pfizer Recent Development
6.5 Sanofi
6.5.1 Sanofi Viral Vaccines Production Sites and Area Served
6.5.2 Sanofi Description, Business Overview and Total Revenue
6.5.3 Sanofi Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Sanofi Products Offered
6.5.5 Sanofi Recent Development
6.6 Bayer
6.6.1 Bayer Viral Vaccines Production Sites and Area Served
6.6.2 Bayer Description, Business Overview and Total Revenue
6.6.3 Bayer Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bayer Products Offered
6.6.5 Bayer Recent Development
6.7 Zoetis
6.6.1 Zoetis Viral Vaccines Production Sites and Area Served
6.6.2 Zoetis Description, Business Overview and Total Revenue
6.6.3 Zoetis Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Zoetis Products Offered
6.7.5 Zoetis Recent Development
6.8 AstraZeneca
6.8.1 AstraZeneca Viral Vaccines Production Sites and Area Served
6.8.2 AstraZeneca Description, Business Overview and Total Revenue
6.8.3 AstraZeneca Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 AstraZeneca Products Offered
6.8.5 AstraZeneca Recent Development
6.9 Johnson
6.9.1 Johnson Viral Vaccines Production Sites and Area Served
6.9.2 Johnson Description, Business Overview and Total Revenue
6.9.3 Johnson Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Johnson Products Offered
6.9.5 Johnson Recent Development
6.10 CSL
6.10.1 CSL Viral Vaccines Production Sites and Area Served
6.10.2 CSL Description, Business Overview and Total Revenue
6.10.3 CSL Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 CSL Products Offered
6.10.5 CSL Recent Development
7 Viral Vaccines Manufacturing Cost Analysis
7.1 Viral Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Viral Vaccines
7.4 Viral Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Viral Vaccines Distributors List
8.3 Viral Vaccines Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Viral Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Viral Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Viral Vaccines by Type (2021-2026)
10.2 Viral Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Viral Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Viral Vaccines by Application (2021-2026)
10.3 Viral Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Viral Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Viral Vaccines by Region (2021-2026)
10.4 North America Viral Vaccines Estimates and Projections (2021-2026)
10.5 Europe Viral Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific Viral Vaccines Estimates and Projections (2021-2026)
10.7 Latin America Viral Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa Viral Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Viral Vaccines Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Viral Vaccines Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Viral Vaccines Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Viral Vaccines Manufacturers Covered in This Study
Table 5. Global Viral Vaccines Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Viral Vaccines Sales Share by Manufacturers (2015-2020)
Table 7. Global Viral Vaccines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Viral Vaccines Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Viral Vaccines Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Viral Vaccines Sales Sites and Area Served
Table 11. Manufacturers Viral Vaccines Product Types
Table 12. Global Viral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Viral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vaccines as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Viral Vaccines Players
Table 16. Global Viral Vaccines Sales (K MT) by Region (2015-2020)
Table 17. Global Viral Vaccines Sales Market Share by Region (2015-2020)
Table 18. Global Viral Vaccines Revenue (Million US$) by Region (2015-2020)
Table 19. Global Viral Vaccines Revenue Market Share by Region (2015-2020)
Table 20. North America Viral Vaccines Sales by Country (2015-2020) (K MT)
Table 21. North America Viral Vaccines Sales Market Share by Country (2015-2020)
Table 22. North America Viral Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Viral Vaccines Revenue Market Share by Country (2015-2020)
Table 24. Europe Viral Vaccines Sales by Country (2015-2020) (K MT)
Table 25. Europe Viral Vaccines Sales Market Share by Country (2015-2020)
Table 26. Europe Viral Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Viral Vaccines Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Viral Vaccines Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Viral Vaccines Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Viral Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Viral Vaccines Revenue Market Share by Region (2015-2020)
Table 32. Latin America Viral Vaccines Sales by Country (2015-2020) (K MT)
Table 33. Latin America Viral Vaccines Sales Market Share by Country (2015-2020)
Table 34. Latin America Viral Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Viral Vaccines Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Viral Vaccines Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Viral Vaccines Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Viral Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Viral Vaccines Revenue Market Share by Country (2015-2020)
Table 40. Global Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 41. Global Viral Vaccines Sales Share by Type (2015-2020)
Table 42. Global Viral Vaccines Revenue (Million US$) by Type (2015-2020)
Table 43. Global Viral Vaccines Revenue Share by Type (2015-2020)
Table 44. Global Viral Vaccines Price (USD/MT) by Type (2015-2020)
Table 45. Global Viral Vaccines Sales (K MT) by Application (2015-2020)
Table 46. Global Viral Vaccines Sales Market Share by Application (2015-2020)
Table 47. Global Viral Vaccines Sales Growth Rate by Application (2015-2020)
Table 48. GSK Viral Vaccines Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. GSK Main Product
Table 52. GSK Recent Development
Table 53. Merck Viral Vaccines Corporation Information
Table 54. Merck Corporation Information
Table 55. Merck Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Novartis Viral Vaccines Corporation Information
Table 59. Novartis Corporation Information
Table 60. Novartis Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Novartis Main Product
Table 62. Novartis Recent Development
Table 63. Pfizer Viral Vaccines Corporation Information
Table 64. Pfizer Corporation Information
Table 65. Pfizer Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Pfizer Main Product
Table 67. Pfizer Recent Development
Table 68. Sanofi Viral Vaccines Corporation Information
Table 69. Sanofi Corporation Information
Table 70. Sanofi Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Sanofi Main Product
Table 72. Sanofi Recent Development
Table 73. Bayer Viral Vaccines Corporation Information
Table 74. Bayer Corporation Information
Table 75. Bayer Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Bayer Main Product
Table 77. Bayer Recent Development
Table 78. Zoetis Viral Vaccines Corporation Information
Table 79. Zoetis Corporation Information
Table 80. Zoetis Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Zoetis Main Product
Table 82. Zoetis Recent Development
Table 83. AstraZeneca Viral Vaccines Corporation Information
Table 84. AstraZeneca Corporation Information
Table 85. AstraZeneca Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. AstraZeneca Main Product
Table 87. AstraZeneca Recent Development
Table 88. Johnson Viral Vaccines Corporation Information
Table 89. Johnson Corporation Information
Table 90. Johnson Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Johnson Main Product
Table 92. Johnson Recent Development
Table 93. CSL Viral Vaccines Corporation Information
Table 94. CSL Corporation Information
Table 95. CSL Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. CSL Main Product
Table 97. CSL Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Viral Vaccines Distributors List
Table 101. Viral Vaccines Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Viral Vaccines Sales (K MT) Forecast by Type (2021-2026)
Table 106. Global Viral Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Viral Vaccines Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Viral Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Viral Vaccines Sales (K MT) Forecast by Application (2021-2026)
Table 110. Global Viral Vaccines Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Viral Vaccines Sales (K MT) Forecast by Region (2021-2026)
Table 112. Global Viral Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Viral Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Viral Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Viral Vaccines
Figure 2. Global Viral Vaccines Sales Market Share by Type: 2020 VS 2026
Figure 3. Attenuated Vaccine Product Picture
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Global Viral Vaccines Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospital
Figure 7. Pharmaceutical Factory
Figure 8. Research Institute
Figure 9. Others
Figure 10. Global Viral Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global Viral Vaccines Sales Capacity (K MT) (2015-2026)
Figure 12. Global Viral Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Viral Vaccines Sales Share by Manufacturers in 2020
Figure 14. Global Viral Vaccines Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viral Vaccines Revenue in 2019
Figure 16. Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Viral Vaccines Sales Market Share by Region (2015-2020)
Figure 18. Global Viral Vaccines Sales Market Share by Region in 2019
Figure 19. Global Viral Vaccines Revenue Market Share by Region (2015-2020)
Figure 20. Global Viral Vaccines Revenue Market Share by Region in 2019
Figure 21. North America Viral Vaccines Sales Market Share by Country in 2019
Figure 22. North America Viral Vaccines Revenue Market Share by Country in 2019
Figure 23. U.S. Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 24. U.S. Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 26. Canada Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Viral Vaccines Sales Market Share by Country in 2019
Figure 28. Europe Viral Vaccines Revenue Market Share by Country in 2019
Figure 29. Germany Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 30. Germany Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 32. France Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.K. Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 36. Italy Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 38. Russia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Viral Vaccines Sales Market Share by Region in 2019
Figure 40. Asia Pacific Viral Vaccines Revenue Market Share by Region in 2019
Figure 41. China Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 42. China Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 44. Japan Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 46. South Korea Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 48. India Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 50. Australia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 52. Taiwan Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 54. Indonesia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 56. Thailand Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 58. Malaysia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 60. Philippines Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 62. Vietnam Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Viral Vaccines Sales Market Share by Country in 2019
Figure 64. Latin America Viral Vaccines Revenue Market Share by Country in 2019
Figure 65. Mexico Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 66. Mexico Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 68. Brazil Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 70. Argentina Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Viral Vaccines Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Viral Vaccines Revenue Market Share by Country in 2019
Figure 73. Turkey Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 74. Turkey Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 76. Saudi Arabia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Viral Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 78. U.A.E Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Viral Vaccines by Type (2015-2020)
Figure 80. Sales Market Share of Viral Vaccines by Type in 2019
Figure 81. Revenue Share of Viral Vaccines by Type (2015-2020)
Figure 82. Revenue Market Share of Viral Vaccines by Type in 2019
Figure 83. Global Viral Vaccines Sales Growth by Type (2015-2020) (K MT)
Figure 84. Global Viral Vaccines Sales Market Share by Application (2015-2020)
Figure 85. Global Viral Vaccines Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Viral Vaccines by Application (2015-2020)
Figure 87. Global Revenue Share of Viral Vaccines by Application in 2020
Figure 88. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Viral Vaccines
Figure 100. Manufacturing Process Analysis of Viral Vaccines
Figure 101. Viral Vaccines Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Viral Vaccines Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 106. North America Viral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Viral Vaccines Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Viral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Viral Vaccines Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Viral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Viral Vaccines Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Viral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Viral Vaccines Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Viral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs